Results 151 to 160 of about 48,720 (296)
Mucosal‐Associated Invariant T Cells in Health and Disease
The roles of MAIT cells in health and disease and their therapeutic applications. In healthy individuals, riboflavin metabolites secreted by commensal bacteria at mucosal sites are presented by MR1, leading to the activation of MAIT cells. Activated MAIT cells can maintain the barrier integrity of mucosal tissues in a steady state or migrate to the ...
Yu Zhao +5 more
wiley +1 more source
ABSTRACT Aim Sleep disruptions are common in hospitalised children. This study described sleep in critically ill and non‐critically ill hospitalised children, including young infants and patients with central nervous system injuries. Methods This observational cohort study included two groups: critically ill children admitted to a paediatric intensive ...
Eris van Twist +9 more
wiley +1 more source
Thyroid function test in diabetic ketoacidosis
Background Metabolism of thyroid hormones is influenced by acute systemic illnesses including diabetic ketoacidosis. In these cases T3 level is usually decreased and this condition is called â low T3 syndromeâ which is usually reversed by treating the
Asadi, R. +3 more
core
The Crosstalk Between Diabetes and Alzheimer's Disease: A Molecular Perspective
Increasing evidence indicates an association between type 2 diabetes mellitus and Alzheimer’s disease, contributing to the proposed concept of AD as “type 3 diabetes.” Shared biological features such as impaired insulin signaling, chronic inflammation, mitochondrial dysfunction, and oxidative stress have been observed in both T2DM and AD.
Deniz Catakli +3 more
wiley +1 more source
Euglycemic ketoacidosis in a nondiabetic patient receiving dapagliflozin for heart failure. [PDF]
Silveira G +4 more
europepmc +1 more source
Disproportionate reporting of euglycaemic and diabetic ketoacidosis with SGLT-2 inhibitors across expanding cardiorenal indications: a cross-database study of FAERS and JADER. [PDF]
Chen J +5 more
europepmc +1 more source
Charlotte J, Frise, Lucy, Mackillop
openaire +2 more sources
Class effect beyond glucose: Implications of the LEGEND‐T2DM findings for cardiovascular outcomes
Journal of Diabetes Investigation, EarlyView.
Yuexing Liu, Weiping Jia
wiley +1 more source
ABSTRACT Background Individuals living with type 1 diabetes (T1D) are at increased risk for cardiovascular (CV) and renal complications, yet therapeutic strategies specifically targeting cardiorenal risk reduction in this population remain limited. The role of glucagon‐like peptide‐1 (GLP‐1)‐based therapies in T1D remains unclear.
Anastasios Tentolouris +5 more
wiley +1 more source
Ketoacidosis at diagnosis of diabetes mellitus type 1: impact of the COVID-19 pandemic. [PDF]
Silva DBD +3 more
europepmc +1 more source

